Zuclopenthixol decanoate

• Description :

  Zuclopenthixol decanoate is a long-acting agent for schizophrenia and other serious mental illnesses research[1].

• UNSPSC :

  12352005

• Hazard Statement :

  H302

• Target :

  Others

• Type :

  Reference compound

• Related Pathways :

  Others

• Applications :

  Neuroscience-Neuromodulation

• Field of Research :

  Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/zuclopenthixol-decanoate.html

• Solubility :

  10 mM in DMSO

• Smiles :

  CCCCCCCCCC(OCCN1CCN(CC1)CC/C=C2C3=C(C=CC(Cl)=C3)SC4=C\2C=CC=C4)=O

• Molecular Formula :

  C32H43ClN2O2S

• Molecular Weight :

  555.21

• Precautions :

  P264-P270-P330-P501

• References & Citations :

  [1]Manzaneque JM, et al. An ethopharmacological assessment of the effects of zuclopenthixol on agonistic interactions in male mice. Methods Find Exp Clin Pharmacol. 1999 Jan-Feb;21 (1) :11-5. |[2]E Coutinho, et al. Zuclopenthixol decanoate for schizophrenia and other serious mental illnesses. Cochrane Database Syst Rev. 2000;1999 (2) :CD001164.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [64053-00-5]